Stay updated on Sorafenib Post-Liver Transplant in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Sorafenib Post-Liver Transplant in Liver Cancer Clinical Trial page.

Latest updates to the Sorafenib Post-Liver Transplant in Liver Cancer Clinical Trial page
- Check4 days agoChange DetectedAdded a broader list of study locations by state (Alabama, California, Colorado, Connecticut, District of Columbia, Georgia, Illinois, Louisiana, Maryland, Massachusetts, Michigan, Nebraska, New Jersey, New York, Ohio, Oklahoma, Pennsylvania, Tennessee, Texas) and updated the revision to v3.3.3; removed the previous list corresponding to v3.3.2.SummaryDifference2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedRevision label updated from v3.3.1 to v3.3.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check33 days agoChange DetectedThe page's revision label was updated from v3.2.0 to v3.3.1.SummaryDifference0.0%

- Check40 days agoChange DetectedRemoved the site-wide notice about government funding and operating status related to NIH facilities. This messaging previously informed users about potential delays and where to check status.SummaryDifference0.3%

- Check54 days agoChange DetectedMinor UI/layout tweaks and timestamp updates appear on the page; core study content such as objectives, eligibility criteria, outcomes, and listed locations remains unchanged.SummaryDifference0.3%

- Check83 days agoChange Detected- Added a broad government-status notice and updated operating details (v3.2.0). - Removed the Adult hepatocellular carcinoma resource listing and the old v3.1.0 revision.SummaryDifference3%

Stay in the know with updates to Sorafenib Post-Liver Transplant in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sorafenib Post-Liver Transplant in Liver Cancer Clinical Trial page.